Clinical Trial Update: Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397

View source ↗

Summary

This clinical trial update reports on biomarker analyses from patients with metastatic or recurrent head and neck cancer treated with cisplatin and cetuximab in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Head and Neck Cancer | Status: COMPLETED